Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-23

FDA Approved: BRIVARACETAM — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Lupin Pharmaceuticals' generic version of brivaracetam through an original ANDA, expanding access to an antiseizure medication. The drug is ind…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIVARACETAM (brivaracetam)

Snippet

ORIG AP for BRIVARACETAM (BRIVARACETAM)